REFERENCES
1. Xanthos T, Giannakopoulos N, Papadimitriou L. Lipomatous hypertrophy of the interatrial septum: a pathological and clinical approach. International journal of cardiology. 2007;121(1):4-8.
2. Kılıçkap G. A case with a giant interatrial septal lipomatous hypertrophy, and thickened epicardial and visceral fat: Different faces of a common metabolic problem? Anatolian Journal of cardiology. 2018;19(6):417.
3. Rigatelli G, Dell’Avvocata F, Braggion G, Giordan M, Chinaglia M, Cardaioli P. Persistent venous valves correlate with increased shunt and multiple preceding cryptogenic embolic events in patients with patent foramen ovale: an intracardiac echocardiographic study. Catheterization and Cardiovascular Interventions. 2008;72(7):973-6.
4. Burke AP, Litovsky S, Virmani R. Lipomatous hypertrophy of the atrial septum presenting as a right atrial mass. The American journal of surgical pathology. 1996;20(6):678-85.
5. Kleiman AM, Harding LM, Bechtel AJ. Concomitant lipomatous hypertrophy and left atrial mass: distinguishing benign from malignant. Echocardiography. 2018;35(4):534-6.
6. Gopal DJ, Han Y, Silvestry FE, Ferrari VA. Atypical presentation of lipomatous hypertrophy of the interatrial septum: a case report. European Heart Journal: Case Reports. 2019;3(4):1.
7. Sparrow PJ, Kurian JB, Jones TR, Sivananthan MU. MR imaging of cardiac tumors. Radiographics. 2005;25(5):1255-76.
8. Motwani M, Kidambi A, Herzog BA, Uddin A, Greenwood JP, Plein S. MR imaging of cardiac tumors and masses: a review of methods and clinical applications. Radiology. 2013;268(1):26-43.
9. Dong E. Hongru Du, and Lauren Gardner. 2020.“. An Interactive Web-Based Dashboard to Track COVID-19 in Real Time.30120-1.
10. Esposito A, De Cobelli F, Ironi G, Marra P, Canu T, Mellone R, et al. CMR in the assessment of cardiac masses: primary malignant tumors. JACC: Cardiovascular Imaging. 2014;7(10):1057-61.